Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cilofexor in adults with primary sclerosing cholangitis without cirrhosis has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangiopathy
• Sclerosing Cholangitis

Drugs mentioned

• Cilofexor (cilofexor)

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-12